Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros













Base de datos
Intervalo de año de publicación
1.
Int J Biol Macromol ; 120(Pt A): 641-649, 2018 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-30171942

RESUMEN

Astragalus polysaccharides (APS) were treated with different gamma irradiation doses (10, 25, 50, 100 and 150 kGy) to investigate the effects of gamma radiation processing on structure, physicochemical and immunomodulatory properties. The results revealed both the number-average and weight-average molecular weight of APS significantly decreased with increasing irradiation dose, whereas the solubility was increased after irradiation. A decrease in the apparent viscosity, as well as an increase in amount of small fragments of APS granules was also observed with increasing irradiation dose. FT-IR spectra indicated that gamma irradiation introduced no significant changes into the functional group status of APS. High irradiation dose (>50 kGy) caused a significant increase of yellowness and a slightly decrease of thermal stability of APS. Further, the immunomodulatory activity of irradiated APS was evaluated on Caco2 cells. APS irradiated at dose of 25 kGy exhibited the highest ability to induce nitric oxide production and up-regulate the mRNA expression of inflammatory cytokines, occludin, zonula occludens protein-1 (ZO-1) and toll-like receptor 4 (TLR4), as well as the protein expression of ZO-1 and TLR4. These findings indicate that gamma irradiation modification with a proper dose enhance immunomodulatory activity of APS by improving physicochemical properties without changing the functional groups.


Asunto(s)
Planta del Astrágalo/química , Rayos gamma , Regulación de la Expresión Génica/efectos de los fármacos , Factores Inmunológicos/efectos de la radiación , Polisacáridos/efectos de la radiación , Células CACO-2 , Supervivencia Celular/efectos de los fármacos , Color , Citocinas/agonistas , Citocinas/genética , Citocinas/inmunología , Relación Dosis-Respuesta Inmunológica , Relación Dosis-Respuesta en la Radiación , Humanos , Factores Inmunológicos/aislamiento & purificación , Factores Inmunológicos/farmacología , Peso Molecular , Óxido Nítrico/agonistas , Óxido Nítrico/biosíntesis , Óxido Nítrico/inmunología , Ocludina/agonistas , Ocludina/genética , Ocludina/inmunología , Polisacáridos/aislamiento & purificación , Polisacáridos/farmacología , Solubilidad/efectos de la radiación , Receptor Toll-Like 4/agonistas , Receptor Toll-Like 4/genética , Receptor Toll-Like 4/inmunología , Viscosidad/efectos de la radiación , Proteína de la Zonula Occludens-1/agonistas , Proteína de la Zonula Occludens-1/genética , Proteína de la Zonula Occludens-1/inmunología
2.
Biochem Pharmacol ; 120: 63-71, 2016 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-27641813

RESUMEN

Despite pharmacological treatment, bronchial hyperresponsiveness continues to deteriorate as airway remodelling persists in airway inflammation. Previous studies have demonstrated that the phytocannabinoid Δ9-tetrahydrocannabinol (THC) reverses bronchoconstriction with an anti-inflammatory action. The aim of this study was to investigate the effects of THC on bronchial epithelial cell permeability after exposure to the pro-inflammatory cytokine, TNFα. Calu-3 bronchial epithelial cells were cultured at air-liquid interface. Changes in epithelial permeability were measured using Transepithelial Electrical Resistance (TEER), then confirmed with a paracellular permeability assay and expression of tight junction proteins by Western blotting. Treatment with THC prevented the TNFα-induced decrease in TEER and increase in paracellular permeability. Cannabinoid CB1 and CB2 receptor-like immunoreactivity was found in Calu-3 cells. Subsequent experiments revealed that pharmacological blockade of CB2, but not CB1 receptor inhibited the THC effect. Selective stimulation of CB2 receptors displayed a similar effect to that of THC. TNFα decreased expression of the tight junction proteins occludin and ZO-1, which was prevented by pre-incubation with THC. These data indicate that THC prevents cytokine-induced increase in airway epithelial permeability through CB2 receptor activation. This highlights that THC, or other cannabinoid receptor ligands, could be beneficial in the prevention of inflammation-induced changes in airway epithelial cell permeability, an important feature of airways diseases.


Asunto(s)
Antiinflamatorios no Esteroideos/farmacología , Bronquios/efectos de los fármacos , Agonistas de Receptores de Cannabinoides/farmacología , Dronabinol/farmacología , Alucinógenos/farmacología , Receptor Cannabinoide CB2/agonistas , Mucosa Respiratoria/efectos de los fármacos , Algoritmos , Antiinflamatorios no Esteroideos/metabolismo , Bronquios/inmunología , Bronquios/metabolismo , Agonistas de Receptores de Cannabinoides/metabolismo , Antagonistas de Receptores de Cannabinoides/farmacología , Línea Celular Tumoral , Permeabilidad de la Membrana Celular/efectos de los fármacos , Dronabinol/metabolismo , Impedancia Eléctrica , Alucinógenos/metabolismo , Humanos , Interleucina-1beta/antagonistas & inhibidores , Interleucina-1beta/metabolismo , Cinética , Ligandos , Ocludina/agonistas , Ocludina/antagonistas & inhibidores , Ocludina/metabolismo , Permeabilidad/efectos de los fármacos , Receptor Cannabinoide CB2/antagonistas & inhibidores , Receptor Cannabinoide CB2/metabolismo , Mucosa Respiratoria/inmunología , Mucosa Respiratoria/metabolismo , Proteínas de Uniones Estrechas/agonistas , Proteínas de Uniones Estrechas/antagonistas & inhibidores , Proteínas de Uniones Estrechas/metabolismo , Uniones Estrechas/efectos de los fármacos , Uniones Estrechas/metabolismo , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores , Factor de Necrosis Tumoral alfa/metabolismo , Proteína de la Zonula Occludens-1/agonistas , Proteína de la Zonula Occludens-1/antagonistas & inhibidores , Proteína de la Zonula Occludens-1/metabolismo
3.
Nutr Cancer ; 68(7): 1225-33, 2016 10.
Artículo en Inglés | MEDLINE | ID: mdl-27564600

RESUMEN

All-trans-retinoic acid (ATRA) inhibits the invasive and metastatic potentials of various cancer cells. However, the underlying mechanism is unclear. Here, we demonstrate that ATRA inhibited colorectal cancer cells RKO (human colon adenocarcinoma cell) migration by downregulating cell movement and increasing cell adhesion. ATRA inhibited the expression and activation of myosin light chain kinase (MLCK) in RKO cells, while the expression level of MLC phosphatase (MLCP) had no change in RKO cells treated with or without ATRA. The expression and activity of MLC was also inhibited in RKO cells exposed to ATRA. Intriguingly, ATRA increased the expression of occludin messenger RNA (mRNA) and protein and its localization on cell membrane. However, ATRA did not change the expression of zonula occludens 1 (ZO-1), but increased the accumulation of ZO-1 on RKO cells membrane. ML-7, an inhibitor of MLCK, significantly inhibited RKO cell migration. Furthermore, knockdown of endogenous MLCK expression inhibited RKO migration. Mechanistically, we showed that MAPK-specific inhibitor PD98059 enhanced the inhibitory effect of ATRA on RKO migration. In contrast, phorbol 12-myristate 13-acetate (PMA) attenuated the effects of ATRA in RKO cells. Moreover, knocking down endogenous extracellular signal-regulated kinase (ERK) expression inhibited MLCK expression in the RKO cells. In conclusion, ATRA inhibits RKO migration by reducing MLCK expression via extracellular signal-regulated kinase 1/Mitogen-activated protein kinase (ERK1/MAPK) signaling pathway.


Asunto(s)
Antineoplásicos/farmacología , Neoplasias Colorrectales/tratamiento farmacológico , Regulación hacia Abajo/efectos de los fármacos , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Sistema de Señalización de MAP Quinasas/efectos de los fármacos , Quinasa de Cadena Ligera de Miosina/antagonistas & inhibidores , Tretinoina/farmacología , Carcinógenos/farmacología , Línea Celular Tumoral , Membrana Celular/efectos de los fármacos , Membrana Celular/metabolismo , Membrana Celular/patología , Movimiento Celular/efectos de los fármacos , Neoplasias Colorrectales/metabolismo , Neoplasias Colorrectales/patología , Activación Enzimática/efectos de los fármacos , Humanos , Cinética , Quinasa de Cadena Ligera de Miosina/genética , Quinasa de Cadena Ligera de Miosina/metabolismo , Proteínas de Neoplasias/antagonistas & inhibidores , Proteínas de Neoplasias/genética , Proteínas de Neoplasias/metabolismo , Ocludina/agonistas , Ocludina/antagonistas & inhibidores , Ocludina/genética , Ocludina/metabolismo , Inhibidores de Proteínas Quinasas/farmacología , Interferencia de ARN , Uniones Estrechas/efectos de los fármacos , Uniones Estrechas/metabolismo , Uniones Estrechas/patología , Proteína de la Zonula Occludens-1/agonistas , Proteína de la Zonula Occludens-1/antagonistas & inhibidores , Proteína de la Zonula Occludens-1/genética , Proteína de la Zonula Occludens-1/metabolismo
4.
Toxicol Sci ; 148(1): 311-29, 2015 11.
Artículo en Inglés | MEDLINE | ID: mdl-26424772

RESUMEN

Cadmium (Cd) causes male infertility. There is the need to identify safe treatments counteracting this toxicity. Flavocoxid is a flavonoid that induces a balanced inhibition of cyclooxygenase (COX)-1 and COX-2 peroxidase moieties and of 5-lipoxygenase (LOX) and has efficacy in the male genitourinary system. We investigated flavocoxid effects on Cd-induced testicular toxicity in mice. Swiss mice were divided into 4 groups: 2 control groups received 0.9% NaCl (vehicle; 1 ml/kg/day) or flavocoxid (20 mg/kg/day ip); 2 groups were challenged with cadmium chloride (CdCl2; 2 mg/kg/day ip) and administered with vehicle or flavocoxid. The treatment lasted for 1 or 2 weeks. The testes were processed for biochemical and morphological studies. CdCl2 increased phosphorylated extracellular signal-regulated kinase (p-ERK) 1/2, tumor necrosis factor (TNF)-α, COX-2, 5-LOX, malondialdehyde (MDA), B-cell-lymphoma (Bcl)-2-associated X protein (Bax), follicle-stimulating hormone (FSH), luteinizing hormone (LH), transforming growth factor (TGF) -ß3, decreased Bcl-2, testosterone, inhibin-B, occludin, N-Cadherin, induced structural damages in the testis and disrupted the blood-testis barrier. Many TUNEL-positive germ cells and changes in claudin-11, occludin, and N-cadherin localization were present. Flavocoxid administration reduced, in a time-dependent way, p-ERK 1/2, TNF-α, COX-2, 5-LOX, MDA, Bax, FSH, LH, TGF-ß3, augmented Bcl-2, testosterone, inhibin B, occludin, N-Cadherin, and improved the structural organization of the testis and the blood-testis barrier. Few TUNEL-positive germ cells were present and a morphological retrieval of the intercellular junctions was observed. In conclusion, flavocoxid has a protective anti-inflammatory, antioxidant, and antiapoptotic function against Cd-induced toxicity in mice testis. We suggest that flavocoxid may play a relevant positive role against environmental levels of Cd, otherwise deleterious to gametogenesis and tubular integrity.


Asunto(s)
Antiinflamatorios no Esteroideos/uso terapéutico , Barrera Hematotesticular/efectos de los fármacos , Intoxicación por Cadmio/prevención & control , Catequina/uso terapéutico , Infertilidad Masculina/prevención & control , Túbulos Seminíferos/efectos de los fármacos , Espermatogénesis/efectos de los fármacos , Animales , Antioxidantes/uso terapéutico , Apoptosis/efectos de los fármacos , Biomarcadores/metabolismo , Barrera Hematotesticular/metabolismo , Barrera Hematotesticular/patología , Barrera Hematotesticular/ultraestructura , Cadherinas/agonistas , Cadherinas/antagonistas & inhibidores , Cadherinas/metabolismo , Intoxicación por Cadmio/metabolismo , Intoxicación por Cadmio/patología , Intoxicación por Cadmio/fisiopatología , Combinación de Medicamentos , Infertilidad Masculina/etiología , Peroxidación de Lípido/efectos de los fármacos , Masculino , Ratones Endogámicos C57BL , Ocludina/agonistas , Ocludina/antagonistas & inhibidores , Ocludina/metabolismo , Estrés Oxidativo/efectos de los fármacos , Fosforilación/efectos de los fármacos , Procesamiento Proteico-Postraduccional/efectos de los fármacos , Túbulos Seminíferos/metabolismo , Túbulos Seminíferos/patología , Túbulos Seminíferos/ultraestructura , Uniones Estrechas/efectos de los fármacos , Uniones Estrechas/metabolismo , Uniones Estrechas/patología , Uniones Estrechas/ultraestructura
5.
Biosci Biotechnol Biochem ; 79(1): 130-7, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25175351

RESUMEN

We investigated the effect of theaflavins (TFs) on membrane barrier of Caco-2 cells. For fluorescein-transport experiments, the apparent permeability (Papp) of fluorescein in Caco-2 cells pretreated with 20 µM TFs were significantly decreased compared with that in untreated cells. Although the respective monomeric catechins did not show any Papp reduction, purpurogallin pretreatment resulted in a significant Papp reduction similar to that of TF-3'-O-gallate (TF3'G) pretreatment. This indicates that the benzotropolone moiety may play a crucial role in the Papp reduction or tight junction (TJ)-closing effect induced by TFs. In TF-3'-O-gallate-pretreated Caco-2 cells, fluorescein transport was completely restored by compound C (AMPK inhibitor). In addition, TF3'G significantly increased both the mRNA and protein expression of TJ-related proteins (occludin, claudin-1, and ZO-1) as well as the phosphorylation of AMPK. It was, thus, concluded that TFs could enhance intestinal barrier function by increasing the expression of TJ-related proteins through the activation of AMPK in Caco-2 cells.


Asunto(s)
Proteínas Quinasas Activadas por AMP/genética , Antioxidantes/farmacología , Benzocicloheptenos/farmacología , Biflavonoides/farmacología , Catequina/farmacología , Fluoresceína/metabolismo , Ácido Gálico/análogos & derivados , Proteínas Quinasas Activadas por AMP/antagonistas & inhibidores , Proteínas Quinasas Activadas por AMP/metabolismo , Células CACO-2 , Permeabilidad de la Membrana Celular/efectos de los fármacos , Claudina-1/agonistas , Claudina-1/genética , Claudina-1/metabolismo , Relación Dosis-Respuesta a Droga , Ácido Gálico/farmacología , Regulación de la Expresión Génica , Humanos , Ocludina/agonistas , Ocludina/genética , Ocludina/metabolismo , Inhibidores de Proteínas Quinasas/farmacología , ARN Mensajero/antagonistas & inhibidores , ARN Mensajero/genética , ARN Mensajero/metabolismo , Transducción de Señal , Relación Estructura-Actividad , Uniones Estrechas/efectos de los fármacos , Uniones Estrechas/metabolismo , Proteína de la Zonula Occludens-1/agonistas , Proteína de la Zonula Occludens-1/genética , Proteína de la Zonula Occludens-1/metabolismo
6.
J Agric Food Chem ; 61(22): 5291-7, 2013 Jun 05.
Artículo en Inglés | MEDLINE | ID: mdl-23668856

RESUMEN

The aim of this study was to determine the protective effect of quercetin, epigallocatechingallate, resveratrol, and rutin against the disruption of epithelial integrity induced by indomethacin in Caco-2 cell monolayers. Indomethacin decreased the transepithelial electrical resistance and increased the permeability of the monolayers to fluorescein-dextran. These alterations were abolished by all the tested polyphenols but rutin, with quercetin being the most efficient. The protective effect of quercetin was associated with its capacity to inhibit the redistribution of ZO-1 protein induced in the tight junction by indomethacin or rotenone, a mitochondrial complex-I inhibitor, and to prevent the decrease of ZO-1 and occludin expression induced by indomethacin. The fact that the antioxidant polyphenols assayed in this study differ in their protective capacity against the epithelial damage induced by indomethacin suggests that this damage is due to the ability of this agent to induce not only oxidative stress but also mitochondrial dysfunction.


Asunto(s)
Antiinflamatorios no Esteroideos/antagonistas & inhibidores , Antioxidantes/metabolismo , Enterocitos/metabolismo , Alimentos Funcionales/análisis , Indometacina/antagonistas & inhibidores , Ocludina/metabolismo , Proteína de la Zonula Occludens-1/metabolismo , Antiinflamatorios no Esteroideos/efectos adversos , Antioxidantes/análisis , Células CACO-2 , Catequina/análogos & derivados , Catequina/análisis , Catequina/metabolismo , Enterocitos/efectos de los fármacos , Regulación de la Expresión Génica/efectos de los fármacos , Humanos , Indometacina/efectos adversos , Ocludina/agonistas , Ocludina/antagonistas & inhibidores , Ocludina/genética , Permeabilidad/efectos de los fármacos , Polifenoles/análisis , Polifenoles/metabolismo , Transporte de Proteínas/efectos de los fármacos , Quercetina/análisis , Quercetina/metabolismo , Resveratrol , Estilbenos/análisis , Estilbenos/metabolismo , Uniones Estrechas/efectos de los fármacos , Proteína de la Zonula Occludens-1/agonistas , Proteína de la Zonula Occludens-1/antagonistas & inhibidores , Proteína de la Zonula Occludens-1/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA